Thursday, February 4, 2016

What do Zika, Ebola and Lyme have in common?



Lyme Disease.Org Logo
What do Zika, Ebola and Lyme have in common?

Zika, Ebola and Lyme disease are emerging infectious diseases that have spread from animals to humans. 

What else do they have in common? And what public health tools used in Zika and Ebola could help prevent, detect, and treat Lyme?  

Hard-earned "Lyme education" shouldn't go to waste

She worked in the entertainment industry for 30 years. Then, misdiagnosed Lyme disease knocked her flat. Eventually, she found the treatment she needed and is now in remission. 

"I've learned a lot about what works for me through years of treatment. And I don't want all this 'education' to go to waste. That's why I've signed up for MyLymeData." READ MORE.

Have you signed up for MyLymeData? It promises to be the largest study of chronic Lyme patients EVER. You could help us find a cure for Lyme disease. Click here to learn more.

LymeDisease.org, publisher of The Lyme Times, is the Lyme community's leading source of news, information, and health policy analysis. 
     





Copyright © 2016. All Rights Reserved.

LymeDisease.org, PO Box 1352, Chico, CA 95927


How ticks work

Many tick species have eyes and can detect color and movement. Hard and soft ticks can detect carbon dioxide (CO2) that animals produce as they exhale. By following these signs, ticks have a good chance of finding hosts.   

What adult deer ticks look like

Adult deer ticks have no white markings on the dorsal area nor do they have eyes or festoons.




Wednesday, February 3, 2016

Borrelia burgdorferi BBK32 Inhibits the Classical Pathway...

Pretty technical, but if biology is up your alley…

Author Summary

The human complement system is a connected network of blood proteins capable of recognizing and eliminating microbial intruders. To avoid the destructive force of complement activation, many microorganisms that enter the bloodstream express molecules that disrupt key steps of the complement cascade by interacting with specific complement components. In this study we show that the causative agent of Lyme disease, Borrelia burgdorferi, expresses a surface-protein termed BBK32 that targets and inhibits the first component of complement, designated C1.

Upon binding to human C1, BBK32 traps this initiating protease complex of the classical pathway of complement in an inactive state, and prevents the downstream proteolytic events of the pathway.

Our study defines a new mechanism by which microbes are able to escape the human innate immune system and identifies complement protease C1r as a previously unknown target of bacterial anti-complement molecules. Thus, discovery of the complement inhibitory activity of the borrelial protein BBK32 significantly advances our understanding of how disease-causing bacteria survive in immune competent hosts.

http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005404